Literature DB >> 1705155

n-hexane induces parkinsonism in rodents.

G Pezzoli1, S Ricciardi, C Masotto, C B Mariani, A Carenzi.   

Abstract

A case of human parkinsonism, due to n-hexane exposure, was recently described. On the basis of this observation, we treated mice and rats with n-hexane and its principle toxic metabolite 2,5-hexanedione. The mice underwent a chronic treatment intraperitoneum, the rats were treated stereotaxically into the substantia nigra. At biochemical analysis of the striata, dopamine and homovanillic acid levels were significantly lower compared with control animals; norepinephrine, serotonin, 5-hydroxindolacetic acid levels were unchanged. The rats treated with 2,5-hexanedione showed an apomorphine-induced rotational behavior significantly higher compared to controls. Since n-hexane and its metabolites are environmental contaminants and by-products of endogenous metabolic pathways, we propose that they may play a role in inducing parkinsonism in humans.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1705155     DOI: 10.1016/0006-8993(90)90801-h

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

Review 1.  Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence.

Authors:  Edward A Lock; Jing Zhang; Harvey Checkoway
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-07       Impact factor: 4.219

2.  2,5-Hexanedione induces dopaminergic neurodegeneration through integrin αMβ2/NADPH oxidase axis-mediated microglial activation.

Authors:  Cong Zhang; Liyan Hou; Jie Yang; Yuning Che; Fuqiang Sun; Huihua Li; Qingshan Wang
Journal:  Cell Death Dis       Date:  2018-01-19       Impact factor: 8.469

Review 3.  Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases.

Authors:  Miguel Chin-Chan; Juliana Navarro-Yepes; Betzabet Quintanilla-Vega
Journal:  Front Cell Neurosci       Date:  2015-04-10       Impact factor: 5.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.